Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Aclaris Therapeutics
Business Segments
Business Segments
Research And Development Expense Personnel Charges
Research And Development Expense Personnel Charges
Aclaris Therapeutics
·
Business Segments
·
1 segment
Breakdown
Segments
Business Segments
View metric
Quarterly
Annual
TTM
Segment
Q1 '26
Business Segments
$3.28M
Total
$3.28M